glp-1 controversy Hims & Hers, and the Brewing Compounding Hims & Hers, and the
Description
Why Mayntain
New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes
Nutrition-dense, fibre-rich and designed to adapt to your appetite
Featuring 4 patented ingredients clinically-studied to support natural GLP-1 production, satiety, fat metabolism and stable energy.
Unlike most drink mixes loaded with sugar and...
The $10 billion price tag, the bidding war with Novo Nordisk, the lawsuits, it all made for high drama
